DE2905066C2 - Antibiotikum SF-2050B, Verfahren zur Herstellung desselben und antibakterielle Mittel, welche dasselbe enthalten - Google Patents

Antibiotikum SF-2050B, Verfahren zur Herstellung desselben und antibakterielle Mittel, welche dasselbe enthalten

Info

Publication number
DE2905066C2
DE2905066C2 DE2905066A DE2905066A DE2905066C2 DE 2905066 C2 DE2905066 C2 DE 2905066C2 DE 2905066 A DE2905066 A DE 2905066A DE 2905066 A DE2905066 A DE 2905066A DE 2905066 C2 DE2905066 C2 DE 2905066C2
Authority
DE
Germany
Prior art keywords
antibiotic
substance
new
water
aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2905066A
Other languages
German (de)
English (en)
Other versions
DE2905066A1 (de
Inventor
Norio Ezaki
Shigeharu Inouye
Jiro Yokohama Kanagawa Itoh
Tomizo Niwa
Chuhei Nojiri
Yasuaki Ogawa
Kazunori Ohba
Takashi Shomura
Kunikazu Tokio / Tokyo Totsugawa
Yujiro Yokohama Kanagawa Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1502678A external-priority patent/JPS54109901A/ja
Priority claimed from JP53028324A external-priority patent/JPS6044916B2/ja
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Publication of DE2905066A1 publication Critical patent/DE2905066A1/de
Application granted granted Critical
Publication of DE2905066C2 publication Critical patent/DE2905066C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/99—Enzyme inactivation by chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2905066A 1978-02-14 1979-02-10 Antibiotikum SF-2050B, Verfahren zur Herstellung desselben und antibakterielle Mittel, welche dasselbe enthalten Expired DE2905066C2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1502678A JPS54109901A (en) 1978-02-14 1978-02-14 New antibiotic sf-2050 substance and preparation thereof
JP53028324A JPS6044916B2 (ja) 1978-03-14 1978-03-14 新抗生物質ｓｆ−２０５０ｂ物質及びその製造法

Publications (2)

Publication Number Publication Date
DE2905066A1 DE2905066A1 (de) 1979-08-16
DE2905066C2 true DE2905066C2 (de) 1984-11-22

Family

ID=26351092

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2905066A Expired DE2905066C2 (de) 1978-02-14 1979-02-10 Antibiotikum SF-2050B, Verfahren zur Herstellung desselben und antibakterielle Mittel, welche dasselbe enthalten

Country Status (9)

Country Link
US (1) US4220639A (https=)
CA (1) CA1142468A (https=)
CH (1) CH644151A5 (https=)
DE (1) DE2905066C2 (https=)
FR (1) FR2416900A1 (https=)
GB (1) GB2014129B (https=)
IT (1) IT1207884B (https=)
NL (1) NL7901010A (https=)
SE (1) SE447909B (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928569A (en) * 1972-08-09 1975-12-23 Microbial Chem Res Found Two substances inhibiting beta-lactamase and their production
GB1483142A (en) * 1975-03-15 1977-08-17 Beecham Group Ltd Streptomycetal antibiotic

Also Published As

Publication number Publication date
NL7901010A (nl) 1979-08-16
US4220639A (en) 1980-09-02
SE447909B (sv) 1986-12-22
DE2905066A1 (de) 1979-08-16
IT7909342A0 (it) 1979-02-13
SE7901094L (sv) 1979-08-15
CA1142468A (en) 1983-03-08
IT1207884B (it) 1989-06-01
GB2014129A (en) 1979-08-22
GB2014129B (en) 1982-08-25
FR2416900B1 (https=) 1984-12-28
FR2416900A1 (fr) 1979-09-07
CH644151A5 (de) 1984-07-13

Similar Documents

Publication Publication Date Title
DE2552638B2 (de) Thienamycin, Verfahren zu seiner Herstellung und Thienamycin enthaltende Arzneimittel
DE2716836C2 (de) Als Musettamycin und Marcellomycin bezeichnete Anthracyclinglycoside, ein Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE68906825T2 (de) Glycosid-Antibiotika BU-3608D und BU-3608E.
DE2340005A1 (de) Beta-lactamaseinhibitoren und verfahren zu ihrer herstellung
DE68912355T2 (de) Antibiotische Antitumor-Verbindung und Methode zu deren Herstellung.
DE3012014C2 (de) Istamycine, Verfahren zu deren Herstellung sowie Verwendung derselben als antibakterielle Mittel
DE3048421C2 (de) Antibiotische Substanz, Verfahren zu deren Herstellung und antimykotisches Mittel, welches diese enthält
DE2905066C2 (de) Antibiotikum SF-2050B, Verfahren zur Herstellung desselben und antibakterielle Mittel, welche dasselbe enthalten
DE2109854B2 (de) 7beta-(D-5-Amino-5-carboxy valeramido)-3-(carbamoyloxymethyl>7-methoxy-3-cephem-4-carbonsäure und deren Salze, Verfahren zu ihrer Herstellung und solche Verbindungen enthaltende Arzneimittel
DE2004686A1 (de) Antibiotica und Verfahren zu ihrer Herstellung
DE2652677C2 (de) Antibiotica 890A↓1↓ und 890A↓3↓, Verfahren zu ihrer Herstellung und diese Antibiotika enthaltende antibakterielle Mittel
DE2725163C2 (https=)
DE1814735C3 (https=)
DE2236599C3 (de) Fungizides Antibiotikum, sowie Herstellung und Verwendung desselben
DE2516615A1 (de) Neues antibiotikum bn-130 und verfahren zur herstellung desselben
DE2444110A1 (de) Neues antibiotikum
DE1617768A1 (de) Neuartige antibiotische Polyoxine D,E,F,G und H und Verfahren zu ihrer Herstellung
DE926271C (de) Verfahren zur Gewinnung eines neuen Antibiotikums
DE3687189T2 (de) Antitumor- und antimikroben-verbindung, deren mikrobiologische herstellung und deren benutzung als arzneimittel.
DE2039990C2 (de) Neue Antibiotika B-5050 A bis F (Maridomycin I bis VI), Verfahren zu ihrer Herstellung und ihre pharmazeutische Zubereitung
AT361619B (de) Verfahren zur herstellung von neuen antibiotika
AT312167B (de) Verfahren zur Herstellung neuer Antibiotika
DE1492111C (de) Verfahren zur Herstellung von Poly oxm A und B
DE2916155A1 (de) Verbindung dc-11, verfahren zu ihrer herstellung, pharmazeutische zubereitung und mikroorganismenstamm zur durchfuehrung des herstellungsverfahrens
DE2944143C2 (de) Antibiotikum SF-2052, Verfahren zu dessen Herstellung und das Antibiotikum SF-2052 enthaltende antibakterielle Mittel

Legal Events

Date Code Title Description
OAP Request for examination filed
OD Request for examination
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee